[Pulmonary fibrosis caused by methotrexate].
作者信息
Guerra Tapia A, Moreno Izquierdo R, Barrio Fuertes A, Merino Monge E
出版信息
Actas Dermosifiliogr. 1978 Sep-Oct;69(9-10):301-8.
PMID:742454
Abstract
摘要
相似文献
1
[Pulmonary fibrosis caused by methotrexate].[甲氨蝶呤所致的肺纤维化]
Actas Dermosifiliogr. 1978 Sep-Oct;69(9-10):301-8.
2
Methotrexate induced pneumonitis in a young woman with psoriasis and rheumatoid arthritis.
J Rheumatol. 1990 Jul;17(7):980.
3
[A case of methotrexate-induced pneumonitis (author's transl)].1例甲氨蝶呤诱发的肺炎（作者译）
Nihon Kyobu Shikkan Gakkai Zasshi. 1978 Oct;16(10):787-92.
4
[Prescription and surveillance of treatment by a systemic agent or biotherapy in psoriasis].[银屑病全身用药或生物治疗的处方及治疗监测]
Ann Dermatol Venereol. 2010 Apr;137(4 Suppl):8-12. doi: 10.1016/S0151-9638(10)70011-9.
5
A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis.一种肝纤维化合剂？银屑病、甲氨蝶呤与遗传性血色素沉着症。
BMC Dermatol. 2005 Nov 29;5:12. doi: 10.1186/1471-5945-5-12.
6
Pulmonary complications following methotrexate therapy.甲氨蝶呤治疗后的肺部并发症。
J Am Acad Dermatol. 1987 Feb;16(2 Pt 1):373-5. doi: 10.1016/s0190-9622(87)70052-8.
7
[Drug-induced pulmonary granulomatosis].[药物性肺肉芽肿病]
Rev Tuberc Pneumol (Paris). 1972 Jul-Aug;36(5):785-804.
8
Methotrexate-induced diffuse interstitial pulmonary fibrosis.甲氨蝶呤诱导的弥漫性间质性肺纤维化。
South Med J. 1979 Mar;72(3):313-8. doi: 10.1097/00007611-197903000-00023.
9
Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment.2型糖尿病银屑病患者在甲氨蝶呤治疗期间发生肝纤维化的风险很高。
J Hepatol. 2007 Jun;46(6):1111-8. doi: 10.1016/j.jhep.2007.01.024. Epub 2007 Feb 15.
10
[A patient with diffuse lung symptoms].[一名患有弥漫性肺部症状的患者]
Ned Tijdschr Geneeskd. 1978 Jan 28;122(4):124-8.
Zotero 插件